We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Edge Therapeutics, Inc. | NASDAQ:EDGE | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.5036 | 0.50 | 0.53 | 0 | 01:00:00 |
Delaware
|
001-37568
|
26-4231384
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 1.01. |
Entry Into a Material Definitive Agreement.
|
ITEM 7.01. |
Regulation FD Disclosure.
|
ITEM 9.01. |
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
|
Opinion of Dechert LLP
|
||
Form of Subscription Agreement dated April 19, 2017, between Edge Therapeutics, Inc. and certain investors
|
||
23.1
|
Consent of Dechert LLP (included in Exhibit 5.1)
|
|
Press Release, dated April 19, 2017
|
Date:
|
April 19, 2017
|
Edge Therapeutics, Inc.
|
/s/ Brian A. Leuthner
|
||
Name: Brian A. Leuthner
|
||
Title: Chief Executive Officer
|
1 Year EDGE THERAPEUTICS, INC. Chart |
1 Month EDGE THERAPEUTICS, INC. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions